Free shipping on all orders over $ 500

 About 30 results found for searched term "AC 4" (0.015 seconds)

Cat.No.  Name Target
M1684 BMS-599626 EGFR/HER2
AC480
BMS-599626 (AC480) is an orally bioavailable pan-HER tyrosine kinase inhibitor with potential antineoplastic activity.
M1976 Pomalidomide Ligand for E3 Ligase
Actimid, CC-4047
Pomalidomide is the third-generation immunomodulatory agent, functions through interacting with the E3 ligase cereblon and induces degradation of essential Ikaros transcription factors. Pomalidomide is a second generation immunomodulator, TNF-α inhibitor with IC50 of 13 nM.
M2112 LY2835219 mesylate CDK
Abemaciclib, CDK4/6 dual inhibitor
LY2835219 mesylate is an orally available inhibitor of CDK4 and CDK6 with IC50 of 2 nM and 10 nM, respectively.
M2205 Macitentan Endothelin Receptor
ACT-064992
Macitentan is an orally-active, tissue-targeting dual ET receptor antagonist.
M2236 CI-994 HDAC
Tacedinaline, PD 123654
CI-994 (N-acetyl dinaline, PD 123654) is a novel orally active HDAC inhibitor with IC50 of 0.57 μM for HDAC1.
M2823 Loxistatin Acid(E-64C) Cathepsin
NSC 694279, EP 475
Loxistatin Acid (E-64C), a derivative of E-64, is an irreversible and membrane-permeant cysteine protease inhibitor.
M3022 Sodium Phenylbutyrate HDAC
4-PBA sodium; 4-Phenylbutyric acid sodium; Sodium 4-phenylbutyrate; TriButyrate
Sodium Phenylbutyrate (4-PBA sodium) is a transcriptional regulators that act by altering chromatin structure via the modulation of HDAC activity.
M3301 Acetaminophen Animal Modeling
APAP; Paracetamol; Tylenol; 4-Acetamidophenol
Acetaminophen is a COX inhibitor for COX-1 and COX-2 with IC50 of 113.7 μM and 25.8 μM, respectively. *The compound is unstable in solutions, freshly prepared is recommended
M3405 AR-42 HDAC
HDAC-42
AR-42 is an HDAC inhibitor with IC50 of 30 nM.
M3775 Obeticholic Acid (INT-747) Farnesoid X Receptor
6-ECDCA; UNII-0462Z4S4OZ; OCA; 6-Ethylchenodeoxycholic acid
Obeticholic Acid (INT-747) is a potent, orally active, selective farnesoid X receptor (FXR) agonist with an EC50 of 99 nM.May be used in studies related to non-alcoholic steatohepatitis (NASH).
M4017 Benzoylmesaconine Others
Mesaconine 14-benzoate
Benzoylmesaconine (Mesaconine 14-Benzoate) is the most abundant component of aconite soup, which can be used in studies of rheumatoid arthritis.
M4107 Alisol-A-24-acetate Others
Alisol-A 24-acetate; Alisol A 24-monoacetate; Alisol A monoacetate
Alisol A 24-monoacetate is A natural product.
M4180 Cryptochlorogenic-acid Metabolite/Endogenous Metabolite
4-Caffeoylquinic acid; 4-O-Caffeoylquinic acid
Cryptochlorogenic acid is a natural product.
M4477 Costunlide Apoptosis
(+)-Costunolide; Costunolid; Costus lactone; NSC 106404
Costunlide
M4623 3β-acetoxy-eupha-7-25-dien-24(R)-ol Others
3β-acetoxy-eupha-7-25-dien-24(R)-ol
M4879 Cycloheximide DNA/RNA Synthesis
Naramycin A; Actidione; CHX; FT 3422-2; NM-MCD 80
Cycloheximide is an inhibitor of protein biosynthesis in eukaryotic organisms, with IC50 of 532.5 nM.
M5259 Citarinostat HDAC
ACY-241
Citarinostat (ACY-241) is an orally available selective HDAC6 inhibitor with IC50 of 2.6 nM and 46 nM for HDAC6 and HDAC3, respectively. It has 13 to 18-fold selectivity towards HDAC6 in comparison to HDAC1-3.
M5393 Alcaftadine Histamine Receptor
Lastacaft, R89674, R 89674, R-89674
Alcaftadine is a high affinity ligand for the H1 receptor, with a pKi (8.5) that is comparable with that of other H1 antihistamines. Alcaftadine is also an antagonist for H2 and H4 receptors with no affinity for the H3 receptor.
M5431 Atosiban Acetate Vasopressin Receptor
RW22164 acetate; RWJ22164 acetate
Atosiban (RW22164; Tractocile) Acetate is a nonapeptide, desamino-oxytocin analogue, and a competitive vasopressin/oxytocin receptor antagonist (VOTra). Atosiban inhibits the oxytocin-mediated release of inositol trisphosphate from the myometrial cell membrane.
M5611 Embelin IAP
Embelic acid; Emberine; NSC 91874
Embelin is a cell-permeable benzoquinone compound that exhibits antitumor properties. Specifically antagonizes XIAP-mediated inhibition of caspase-9 activation by directly targeting the Smac and caspase-9 binding domain BIR3 (IC50 = 4.1 uM in a competitive binding assay with Smac peptide).
M6127 TD-4208 AChR/AChE
Revefenacin; GSK1160724
TD-4208 is a novel and potent muscarinic receptor antagonist that has a high affinity and long residence time at the M3 receptor, and demonstrates in vitro kinetic selectivity for M3 over M2 muscarinic receptor subtype and no meaningful off-target activity.
M6182 7ACC1 Monocarboxylate Transporter (MCT)
DEAC; Coumarin D 1421; D 1421
7ACC1(DEAC; Coumarin D 1421; D 1421) selectively interfere with lactate fluxes in the lactate-rich tumor microenvironment; inhibits lactate influx but not efflux in tumor cells expressing MCT1 and MCT4 transporters.
M6392 AC 265347 Calcium-sensing Receptor
AC 265347 is a calcium-sensitive receptor (CaSR) agonist and orthosteric modulator (auto-PAM) with a functional affinity (pKB) of 5.1.AC 265347 is used in the study of hyperparathyroidism and related disorders.
M6393 AC 4 TRP Channel
AC 4 is a photoswitchable TRPV1 channel blocker.
M6394 AC 45594 Others
AC 45594 is a sF-1 inverse agonist.
M6396 AC 55541 Thrombopoietin/Thrombin
AC 55541 is a potent and selective PAR2 agonist.
M7560 Cenerimod S1P Receptor
ACT-334441
Cenerimod (ACT-334441) is a potentially first-in-class (first-in-class), potent, highly selective, orally active sphingosine 1-phosphate 1 (S1P1) receptor agonist with an EC50 value of 2.7 nM for use in studies related to systemic lupus erythematosus (SLE).
M7586 AC-7954 Others
Nonpeptide GPR14 / urotensin-UII (UII) receptor agonist that has an EC50 of 300 nM at the human UII receptor (h-UTR).
M8523 ACT-462206 Others
ACT-462206 is a orally active, brain penetrant, potent and selective dual orexin1/2 receptor antagonist (DORA).
M8711 Delafloxacin Others
Delafloxacinum; RX-3341; WQ-3034; ABT492; ABT 492; ABT-492
Delafloxacin is a fluoroquinolone antibiotic active against both Gram-negative and Gram-positive bacteria such as MRSA.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.